A Phase 1, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Pimozide after Multiple Dose Administration in Subjects with Rheumatoid Arthritis

Status

Not yet recruiting

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-507521-41-01

Acronym

GBP-NIB1-101

Enrollment

Registered

2023-11-20

Start date

Unknown

Completion date

Unknown

Last updated

2023-11-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

rheumatoid arthritis

None listed

Sex/Gender

All

Age

18 Years to No maximum

Bulgaria

None listed

Source: EU CTIS · Data processed: Feb 4, 2026